XML 42 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Quarterly financial data - unaudited
12 Months Ended
Dec. 31, 2022
Quarterly Financial Information Disclosure [Abstract]  
Quarterly financial data - unaudited Quarterly financial data - unaudited
The following tables set forth selected unaudited quarterly financial information for the years ended December 31, 2022 and 2021. The adjustments to the unaudited quarterly financial information below are the same as the Tax Adjustments and Other Adjustments made to the Company's audited consolidated financial statements as discussed in Note 2, "Restatement of consolidated financial statements".
Three Months EndedThree Months Ended
March 31, 2022June 30, 2022
Previously ReportedTax AdjustmentsOther AdjustmentsAs RevisedPreviously ReportedTax AdjustmentsOther AdjustmentsAs Revised
Total revenues$307.5 $— $(2.7)$304.8 $242.7 $— $(0.1)$242.6 
Cost of product sales$80.3 $— $(0.9)$79.4 $91.0 $— $1.2 $92.2 
Cost of CDMO$75.6 $— $(1.6)$74.0 $78.8 $— $1.0 $79.8 
Income (loss) from operations$6.4 $— $0.5 $6.9 $(72.0)$— $(4.3)$(76.3)
Net income (loss)$(3.7)$(1.4)$0.5 $(4.6)$(56.4)$7.8 $(4.3)$(52.9)
Net income (loss) per common share:
Basic$(0.07)$(0.03)$0.01 $(0.09)$(1.13)$0.16 $(0.09)$(1.06)
Diluted$(0.07)$(0.03)$0.01 $(0.09)$(1.13)$0.16 $(0.09)$(1.06)
Three Months EndedThree Months Ended
September 30, 2022December 31, 2022
Previously ReportedTax AdjustmentsOther AdjustmentsAs RestatedPreviously ReportedTax AdjustmentsOther AdjustmentsAs Restated
Total revenues$240.0 $— $(0.1)$239.9 $330.7 $— $(0.5)$330.2 
Cost of product sales$85.5 $— $(0.3)$85.2 $167.3 $— $0.5 $167.8 
Cost of CDMO$63.1 $— $(1.1)$62.0 $52.1 $— $0.6 $52.7 
Income (loss) from operations$(42.0)$— $(3.3)$(45.3)$(65.1)$— $9.8 $(55.3)
Net income (loss)$(75.7)$(8.1)$(3.3)$(87.1)$(88.0)$11.2 $9.8 $(67.0)
Net income (loss) per common share:
Basic$(1.52)$(0.16)$(0.07)$(1.75)$(1.76)$0.22 $0.20 $(1.34)
Diluted$(1.52)$(0.16)$(0.07)$(1.75)$(1.76)$0.22 $0.20 $(1.34)
Three Months EndedThree Months Ended
March 31, 2021June 30, 2021
Previously ReportedOther AdjustmentsAs RevisedPreviously ReportedOther AdjustmentsAs Revised
Total revenues$343.0 $34.0 $377.0 $397.5 $(20.1)$377.4 
Cost of product sales$52.6 $0.2 $52.8 $81.2 $0.2 $81.4 
Cost of CDMO$46.7 $37.7 $84.4 $146.6 $(12.7)$133.9 
Income (loss) from operations$95.4 $(3.2)$92.2 $14.5 $(7.4)$7.1 
Net income (loss)$69.7 $(2.4)$67.3 $4.6 $(5.1)$(0.5)
Net income (loss) per common share:
Basic$1.31 $(0.05)$1.26 $0.09 $(0.10)$(0.01)
Diluted$1.28 $(0.05)$1.23 $0.09 $(0.10)$(0.01)
Three Months EndedThree Months Ended
September 30, 2021December 31, 2021
Previously ReportedOther AdjustmentsAs RevisedPreviously ReportedOther AdjustmentsAs Revised
Total revenues$329.0 $(42.7)$286.3 $723.2 $9.7 $732.9 
Cost of product sales$103.2 $1.1 $104.3 $145.0 $(0.9)$144.1 
Cost of CDMO$114.3 $(36.8)$77.5 $67.9 $1.8 $69.7 
Income (loss) from operations$(34.7)$(10.0)$(44.7)$277.4 $9.4 $286.8 
Net income (loss)$(32.7)$(7.7)$(40.4)$189.3 $3.8 $193.1 
Net income (loss) per common share:
Basic$(0.61)$(0.14)$(0.75)$3.55 $0.07 $3.62 
Diluted$(0.61)$(0.14)$(0.75)$3.53 $0.07 $3.60